Cutaneous Melanoma Clinical Trials

81 clinical trials for Cutaneous Melanoma across international registries, including 27 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors — RECRUITING · PHASE1
• Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours — RECRUITING · PHASE1
• Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer — RECRUITING · PHASE1
• Phase 1 Study of PF-08046033 in Advanced Solid Tumors — RECRUITING · PHASE1
• NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma — RECRUITING
• Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers — RECRUITING · NA
• Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions — RECRUITING · PHASE1
• Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma — RECRUITING · PHASE2
• Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma — RECRUITING
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma — RECRUITING · PHASE2
• EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers — RECRUITING · PHASE2
• Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome — RECRUITING
• Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) — RECRUITING · PHASE2
• 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors — RECRUITING · PHASE1
• ACTengine® IMA203 Combined With mRNA-4203 — RECRUITING · PHASE1
• Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria — RECRUITING
• Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma — RECRUITING · PHASE1
• SUPRAME - ACTENGINE IMA203 VS. INVESTIGATOR'S CHOICE OF TREATMENT IN PREVIOUSLY TREATED, UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA — RECRUITING
• Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma — RECRUITING
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — RECRUITING
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies — RECRUITING · PHASE1
• A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) — RECRUITING · PHASE1
• Neoadjuvant Combination Immunotherapy for Stage III Melanoma — RECRUITING · PHASE2
• The MELAcare Study: A New Method for Surveillance of Melanoma Patients — RECRUITING · NA
• A feasibility study to assess the accuracy of indocyanine green in the identification of sentinel lymph nodes for patients with cutaneous melanoma — COMPLETED · PHASE2
• MelaMEd Online Training for General Practitioners to Improve Melanoma Detection and Management — COMPLETED · NA
• Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) — TERMINATED · PHASE2
• A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors — TERMINATED · PHASE1
• Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) — ACTIVE_NOT_RECRUITING
• Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous Melanoma — TERMINATED · NA
• A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information — NOT_YET_RECRUITING · NA
• Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors — COMPLETED · NA
• MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma — TERMINATED · NA
• Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma — COMPLETED · PHASE1
• Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma — COMPLETED · PHASE2
• Exercise to Boost Response to Checkpoint Blockade Immunotherapy — ACTIVE_NOT_RECRUITING · NA
• Neoadjuvant Atezolizumab in Cutaneous Melanoma — ACTIVE_NOT_RECRUITING · PHASE1
• Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) — ACTIVE_NOT_RECRUITING · PHASE2
• Exercise to Boost Response to Checkpoint Blockade Immunotherapy — ACTIVE_NOT_RECRUITING · PHASE1
• Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS) — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma — ACTIVE_NOT_RECRUITING · PHASE1
• Enhancing Skin Cancer Early Detection and Treatment in Primary Care — COMPLETED · NA
• A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients — NOT_YET_RECRUITING · PHASE3
• A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope) — COMPLETED · NA
• A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). — COMPLETED · PHASE1
• A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search